Simple blood test may predict prostate cancer radiation risks
Diagnosis
Not yet recruiting
This study looks at whether a blood test, called the RILA assay, can predict which prostate cancer patients will have late side effects from a precise type of radiation therapy (SBRT). About 220 men with low- or intermediate-risk prostate cancer will give a blood sample before tr…
Phase: NA • Sponsor: Clinique Sainte Clotilde • Aim: Diagnosis
Last updated Jun 27, 2026 11:02 UTC